Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases (Q34454367)

2 August 2017

1 reference

title

Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases (English)

1 reference

inflammatory bowel diseases

2 August 2017

main subject

0 references

1 reference

1 reference

2 August 2017

1 reference

2 August 2017

P Klose

0 references

J Langhorst

1 reference

2 August 2017

H Wulfert

series ordinal

1 reference

2 August 2017

G J Dobos

series ordinal

1 reference

2 August 2017

J Korzenik

series ordinal

1 reference

2 August 2017

publication date

28 November 2014

1 reference

Journal of Crohn's and Colitis

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

86-106

1 reference

Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Use of complementary and alternative medicine by patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

ABC of complementary medicine. Users and practitioners of complementary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Complementary and alternative medicine use in chronic liver disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Predictors of complementary therapy use among asthma patients: results of a primary care survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - an open pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Mud-bath treatment in spondylitis associated with inflammatory bowel disease--a pilot randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Tormentil for active ulcerative colitis: an open-label, dose-escalating study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Therapy of active Crohn disease with Boswellia serrata extract H 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Effects of gum resin of Boswellia serrata in patients with chronic colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Acupuncture and Moxibustion in the Treatment of Active Crohn’s Disease: A Randomized Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Wormwood (Artemisia absinthium) for Poorly Responsive Early-Stage IgA Nephropathy: A Pilot Uncontrolled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Effects of guided imagery with relaxation training on anxiety and quality of life among patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Andrographis paniculata extract (HMPL-004) for active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

A multi-center, randomized, single-blind, controlled clinical study on the efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Local anaesthetic, antibacterial and antifungal properties of sesquiterpenes from myrrh

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Pharmacological investigations with compounds of chamomile i. on the pharmacology of (-)-alpha-bisabolol and bisabolol oxides (review) (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

[Pharmacological investigations with compounds of chamomile. V. Investigations on the spasmolytic effect of compounds of chamomile and Kamillosan on the isolated guinea pig ileum].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Pharmacological investigations with compounds of chamomile ii. new investigations on the antiphlogistic effects of (-)-alpha-bisabolol and bisabolol oxides (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Chamazulene: an antioxidant-type inhibitor of leukotriene B4 formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Cannabinoid receptors and the regulation of immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

A prospective population-based study of triggers of symptomatic flares in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Predicting relapse in Crohn's disease: a biopsychosocial model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

The effect of electroacupuncture as an adjunct on cyclophosphamide-induced emesis in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Systematic review of acupuncture in cancer care: a synthesis of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Acupuncture and moxibustion for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Moxibustion for ulcerative colitis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Trichuris suis ova in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Systematic review: the efficacy of herbal therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Recent understanding of IBD pathogenesis: implications for future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJU007

Isolation and characterization of several aromatic sesquiterpenes fromCommiphora myrrha

21 January 2018

1 reference

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/FFJ.1193

Identifiers

DOI

10.1093/ECCO-JCC/JJU007

1 reference

2 August 2017

1 reference